<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Clinical Science at North Bristol</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B6F6A78A-A586-4C1D-A512-5169ACE7BB6D"><gtr:id>B6F6A78A-A586-4C1D-A512-5169ACE7BB6D</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Coward</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501901"><gtr:id>B3A4D816-B3AB-48E3-89E3-FBA0BFD0B059</gtr:id><gtr:title>Insulin sensitivity of the human glomerular podocyte: Its biological importance and the role of nephrin in this process.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501901</gtr:grantReference><gtr:abstractText>The leading cause of kidney failure in the world is secondary to diabetes mellitus (DM). In DM there is either a lack of the production, or cellular action, of insulin. The first sign of kidney involvement in DM is the appearance of small amounts of protein in the urine which increases as the kidneys fail. 

The glomerular filtration barrier (GFB) is the part of the kidney that acts as a sieve and prevents protein leaking into the urine from the blood. It is made up of two different cell types called podocytes and endothelial cells. We have developed a unique way of studying these cells in the laboratory by culturing them in dishes. Using these cells we have discovered that podocytes are rapidly insulin sensitive, suggesting that insulin sensitivity of the GFB is important in health. 


Our research intends to study the precise mechanism that insulin exerts its actions on the GFB. We hope that by understanding the insulin responsiveness of the GFB that we may be able to develop new treatments that will treat and prevent urinary protein loss early in disease and ultimately prevent kidney failure in the setting of diabetes.</gtr:abstractText><gtr:technicalSummary>The leading cause of albumin loss into the urine (albuminuria) and end stage renal failure in the Western world is due to abnormalities of the production of insulin (type-1 diabetes) or its cellular effects (type-2 diabetes). Furthermore, albuminuria occurs in non-diabetic patients who are insulin resistant and is importantly also an independent risk factor for cardiovascular morbidity. Therefore understanding the action of insulin on the filtration barrier of the kidney may lead to novel treatment strategies against these major health care problems.
 The filtration barrier of the kidney is found in the glomerulus. It consists of 3 layers: the endothelium lining the blood vessel, the glomerular basement membrane and the podocytes that are adjacent to the urinary space. Intense interest has focused on the role of the podocyte in the prevention of albuminuria in recent years since the landmark discoveries of human single gene defects, that cause early onset massive albuminuria, code for proteins specific to the podocyte. The most severe form of this disease is caused by the mutation of a protein called nephrin. Using the only published immortalised human podocyte cell line in the world which expresses all the phenotypic markers of mature podocytes I have shown differentiated human podocytes are insulin sensitive doubling their glucose uptake within 15 minutes. This is specific to the podocyte in the glomerular filtration barrier as immortalised endothelial cells are insulin resistant. Furthermore by studying podocytes derived from children with mutations of the nephrin gene I have robust evidence that this protein is critical for this process. This project aims to examine the importance of nephrin in the action of insulin on podocytes in three major areas (1) insulin signalling pathways, (2) the reorganisation of the actin cytoskeleton targeting and (3) docking of glucose transporter rich vesicles with the plasma membrane of the cell. Studying the role of nephrin in these three areas will also be important in understanding other fundamental biological properties of the podocyte. 
 Finally the in vivo biological importance of the effect of insulin on the podocyte will be studied by selectively knocking out the insulin receptor in podocytes in an inducible manner. This will allow the podocyte to develop normally before switching the insulin receptor off, and rendering the podocyte insulin resistant. This will be achieved using a tetracycline inducible, podocyte specific, cre-lox mouse model.</gtr:technicalSummary><gtr:fund><gtr:end>2010-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>723410</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>general scientific press</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>43313ED4-F6DE-48EE-B2FF-FC72ED9DD459</gtr:id><gtr:impact>My recent paper entitled &amp;quot;insulin sensitivity of the glomerular podocyte is critical for kidney function&amp;quot; has been picked up, and published in Science news and the New Scientist.

A great deal of interest in the paper and many contacts through the internet.</gtr:impact><gtr:outcomeId>aiXxvJcfKPK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Insulin directly reorganises the glomerular filtration barrier</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>110C2567-25D3-4B52-9E5F-D07C1A83A9FA</gtr:id><gtr:impact>This work has been presented to non-academic members of the hospital team at Bristol Children's hospital

Well received at the meeting.</gtr:impact><gtr:outcomeId>9F304185B5E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University Press release and local media interest in Collaborative European grant investigating diabetic kidney disease</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E3A023EA-0302-4959-9226-7A55C6D52A2D</gtr:id><gtr:impact>The university produced a Press release about the recent Collaborative European grant investigating biomarkers associated with diabetic kidney disease.</gtr:impact><gtr:outcomeId>58c83213a55187.89739807</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bristol.ac.uk/news/2017/february/beat-dkd.html</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>36000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kids Kidney Research fund pilot fund</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Kids Kidney Research</gtr:fundingOrg><gtr:id>1CD0BDAA-0AE8-4273-A6D2-B333E670D0D3</gtr:id><gtr:outcomeId>gVkqX58fyfh0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>136000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kidney Research UK project grant</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:id>AA86EF24-9F36-4D2F-837A-8DB694E28149</gtr:id><gtr:outcomeId>n2VUKPAkTFe0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>199284</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Fellowship</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5DE92EDF-8B81-462C-BB70-B201D4130B48</gtr:id><gtr:outcomeId>AZ4AMb92cSB0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Innovative Medicines Initiative (IMI)</gtr:department><gtr:description>European Union IMI grant &amp;quot;BEAt DKD&amp;quot;</gtr:description><gtr:end>2021-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>BB68ABCE-47C3-4350-B566-6660D93B3F20</gtr:id><gtr:outcomeId>58c8295b51ce08.55368697</gtr:outcomeId><gtr:sector>Multiple</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>KRUK Medical Student Fellowship- Developing a human cystinuria proximal tubular cell model</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:id>AE86CCD6-A2CC-4A46-AACD-3F826E433620</gtr:id><gtr:outcomeId>58c827a160d324.74672110</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Start Up Grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Kids Kidney Research</gtr:fundingOrg><gtr:id>6214AB44-9BA6-450B-AC38-34682E88E794</gtr:id><gtr:outcomeId>AD640D053D30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>562000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>programme grant</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>555B0520-07DF-46F5-A05B-90809669E03A</gtr:id><gtr:outcomeId>G1dDzVghdyT0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>168000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>7576914E-34DC-47C7-AC18-80B667F92E72</gtr:id><gtr:outcomeId>ZmRh2KRHhHZ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>KRUK PhD Fellowship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Kids Kidney Research</gtr:fundingOrg><gtr:id>186A5E54-AAF4-46C4-908B-1D14909AD0B8</gtr:id><gtr:outcomeId>te44CAAoUPM0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>David Telling Charitable Trust</gtr:department><gtr:description>David Telling Research fund (local charity)</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>University Hospitals Bristol NHS Foundation Trust</gtr:fundingOrg><gtr:id>A52F7F23-056B-4A50-962E-F21C33F3A39C</gtr:id><gtr:outcomeId>SwFhKhneNKZ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>As part of the MRC funding I worked with Professor Susan Quaggin in Toronto, Canada and developed mouse models of podocyte insulin resistance.</gtr:description><gtr:id>DD23B3BE-CA58-490A-8E06-66DB81FB46DD</gtr:id><gtr:impact>This model recapitulates features of diabetic nephropathy, which is a conceptual leap in our understanding of this disease process.</gtr:impact><gtr:outcomeId>61975D6D297</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>podocyte specific insulin receptor knockout developmental and inducible models</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a number of cell lines that are stable mRNA knockdowns to investigate biological pathways</gtr:description><gtr:id>7F32096C-3E46-4B78-A803-575BFD65DDF6</gtr:id><gtr:impact>We have been able to interogate insulin and IGF signalling in cells by being able to knock down the receptors (IGF-1 receptor and insulin receptor) using lentiviaral technology.</gtr:impact><gtr:outcomeId>60CE27DCC6D</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>human short hairpin si RNA podocyte models</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F7740541-FEF4-4066-9A06-EDC8EF65343B</gtr:id><gtr:title>An initial evaluation of post-cardiopulmonary bypass acute kidney injury in swine.</gtr:title><gtr:parentPublicationTitle>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c033c81ca05a6742cff694ac6af0510"><gtr:id>0c033c81ca05a6742cff694ac6af0510</gtr:id><gtr:otherNames>Murphy GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1010-7940</gtr:issn><gtr:outcomeId>94A193C6AEF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11577D7A-948B-407F-A618-A38874CE2B3B</gtr:id><gtr:title>Insulin directly stimulates VEGF-A production in the glomerular podocyte.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0507b86744af3f2696af41536021b2e6"><gtr:id>0507b86744af3f2696af41536021b2e6</gtr:id><gtr:otherNames>Hale LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn><gtr:outcomeId>doi_15036_00548_2012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A81AC1DB-BB42-4DBA-8063-019C9FDFAB4C</gtr:id><gtr:title>Podocytes, glucose and insulin.</gtr:title><gtr:parentPublicationTitle>Current opinion in nephrology and hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/805179816d91beda61a61852177a06e4"><gtr:id>805179816d91beda61a61852177a06e4</gtr:id><gtr:otherNames>Welsh GI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1062-4821</gtr:issn><gtr:outcomeId>fSzg4doK5ER</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37B9CFC9-A5BC-4DD1-9799-189CC3A74A26</gtr:id><gtr:title>Meningococcal disease associated with an acute post-streptococcal complement deficiency.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75be1b44f43175c35cf0932dff121784"><gtr:id>75be1b44f43175c35cf0932dff121784</gtr:id><gtr:otherNames>Daskas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>84BA842C301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5291BFA6-9676-4FF6-ABF1-4863D7BC43EE</gtr:id><gtr:title>Podocytes as a target of insulin.</gtr:title><gtr:parentPublicationTitle>Current diabetes reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b010d57a3f9726f685af57ca1e1cea7f"><gtr:id>b010d57a3f9726f685af57ca1e1cea7f</gtr:id><gtr:otherNames>Coward RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1573-3998</gtr:issn><gtr:outcomeId>r3MVjp7pV2r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0137EEC8-34ED-448C-AB57-9DB8B8F50A9B</gtr:id><gtr:title>Nephrin is critical for the action of insulin on human glomerular podocytes.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b010d57a3f9726f685af57ca1e1cea7f"><gtr:id>b010d57a3f9726f685af57ca1e1cea7f</gtr:id><gtr:otherNames>Coward RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>D16410DAE90</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6A5F3BF-F18B-4DAB-A364-CE44D17B3910</gtr:id><gtr:title>The insulin receptor and the kidney.</gtr:title><gtr:parentPublicationTitle>Current opinion in nephrology and hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0507b86744af3f2696af41536021b2e6"><gtr:id>0507b86744af3f2696af41536021b2e6</gtr:id><gtr:otherNames>Hale LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1062-4821</gtr:issn><gtr:outcomeId>pm_15036_26_23104093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72E2B851-544E-40A3-B950-6070B8EC7D0A</gtr:id><gtr:title>Renal stones in paediatric practice</gtr:title><gtr:parentPublicationTitle>Paediatrics and Child Health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3df272579e637d582df7c8132b0e2229"><gtr:id>3df272579e637d582df7c8132b0e2229</gtr:id><gtr:otherNames>Humphreys J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>Thnr5p58pom</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50B5BF91-B395-439B-AE8C-81D32774B725</gtr:id><gtr:title>Regulation of hypoxia-inducible factor 2-a is essential for integrity of the glomerular barrier.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6da93bfb2e15000056301752694b5fb"><gtr:id>e6da93bfb2e15000056301752694b5fb</gtr:id><gtr:otherNames>Ding M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn><gtr:outcomeId>pm_15036_26_23054256</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EEE8200-6B43-4F5D-A771-464C4368425D</gtr:id><gtr:title>Insulin signalling to the kidney in health and disease.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0507b86744af3f2696af41536021b2e6"><gtr:id>0507b86744af3f2696af41536021b2e6</gtr:id><gtr:otherNames>Hale LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>pm_15036_26_23190266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EFC4BB0-7363-44BB-9F12-FA7759507916</gtr:id><gtr:title>Associations among genotype, clinical phenotype, and intracellular localization of trafficking proteins in ARC syndrome.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7617b24e424e111cf0ed36e041ad9d1"><gtr:id>e7617b24e424e111cf0ed36e041ad9d1</gtr:id><gtr:otherNames>Smith H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15036_26_22753090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1736E58-6412-43BC-A8C0-24CE029FB990</gtr:id><gtr:title>Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54ab7e3bb69e1fb68a55a57b0178c654"><gtr:id>54ab7e3bb69e1fb68a55a57b0178c654</gtr:id><gtr:otherNames>Lennon R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>29749479B2C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAF31DE2-9BB5-4D06-AAF6-9894721AE8CB</gtr:id><gtr:title>Insulin-like growth factor-II is produced by, signals to and is an important survival factor for the mature podocyte in man and mouse.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0507b86744af3f2696af41536021b2e6"><gtr:id>0507b86744af3f2696af41536021b2e6</gtr:id><gtr:otherNames>Hale LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_15036_26_23299523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7565B0EB-78EC-4FC5-A62E-062899562E8B</gtr:id><gtr:title>Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54ab7e3bb69e1fb68a55a57b0178c654"><gtr:id>54ab7e3bb69e1fb68a55a57b0178c654</gtr:id><gtr:otherNames>Lennon R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>1DA4F372D1B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4495948A-AE37-40FC-AF15-E8B2B0981268</gtr:id><gtr:title>Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54ab7e3bb69e1fb68a55a57b0178c654"><gtr:id>54ab7e3bb69e1fb68a55a57b0178c654</gtr:id><gtr:otherNames>Lennon R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>ECCF3D57C62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8383B6D4-EEF0-4B85-BE43-1F9627E42C0D</gtr:id><gtr:title>Eosinophilic glomerulonephritis in children in Southwestern Uganda.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45ff1c7ef4b56906b87bb1f95a3972a4"><gtr:id>45ff1c7ef4b56906b87bb1f95a3972a4</gtr:id><gtr:otherNames>Walker A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>A97DD775CD5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75D8BBE5-FBF5-47F0-B86F-9BFD2C71ABC1</gtr:id><gtr:title>Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec0c849e4a8953a08a1521f76110607a"><gtr:id>ec0c849e4a8953a08a1521f76110607a</gtr:id><gtr:otherNames>Keir L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>Wbo1dev5pZr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EE6E48A-459E-475B-9381-AD4F51AB2EDD</gtr:id><gtr:title>A fair reason for failing to thrive.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Education and practice edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e86cd5371782dfb0fb86ff81879f6f1b"><gtr:id>e86cd5371782dfb0fb86ff81879f6f1b</gtr:id><gtr:otherNames>Connor K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1743-0585</gtr:issn><gtr:outcomeId>000F4D8B8EA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07B2B44B-AD55-46BC-A226-9C66639D23B8</gtr:id><gtr:title>Insulin signaling to the glomerular podocyte is critical for normal kidney function.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/805179816d91beda61a61852177a06e4"><gtr:id>805179816d91beda61a61852177a06e4</gtr:id><gtr:otherNames>Welsh GI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>Unp5y3jm2Ao</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501901</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>